Sandra M. Gurrola - 21 Jun 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Signature
/s/ Sandra Gurrola
Issuer symbol
ERNA
Transactions as of
21 Jun 2024
Net transactions value
-$349
Form type
4
Filing time
25 Jun 2024, 16:32:47 UTC
Previous filing
29 Apr 2024
Next filing
10 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Options Exercise +437 +47% 1,365 21 Jun 2024 Direct F1
transaction ERNA Common Stock Tax liability $349 -180 -13% $1.94 1,185 21 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Restricted Stock Units Options Exercise $0 -437 -50% $0.000000 437 21 Jun 2024 Common Stock 437 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit converts into one share of common stock.
F2 On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.